Midazolam and Akathisia - a phase IV clinical study of FDA data

Summary:

Akathisia is reported as a side effect among people who take Midazolam (midazolam), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Clonidine, and have Bipolar disorder.

The phase IV clinical study analyzes which people have Akathisia when taking Midazolam. It is created by eHealthMe based on reports of 11,245 people who have side effects when taking Midazolam from the FDA, and is updated regularly.

What is Midazolam?

Midazolam has active ingredients of midazolam. eHealthMe is studying from 11,246 Midazolam users. Check the latest studies of Midazolam.

What is Akathisia?

Akathisia (a movement disorder characterized by a feeling of inner restlessness) is found to be associated with 440 drugs and 822 conditions by eHealthMe. Check the latest studies of Akathisia.

On Jul, 13, 2026

11,245 people reported to have side effects when taking Midazolam.
Among them, 14 people (0.12%) have Akathisia.

Among these 14 people:

How long have people been on Midazolam when they have Akathisia? *

What is the gender of people who have Akathisia when taking Midazolam? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Akathisia when taking Midazolam? *

What are other drugs people take besides Midazolam? *

What are other side effects people have besides Akathisia? *

Weight Increased: 4 people, 28.57%
Impatience (restlessness): 4 people, 28.57%
Bipolar Disorder (mood disorder): 4 people, 28.57%
Dry Eyes (lack of adequate tears): 4 people, 28.57%
Dry Mouth: 4 people, 28.57%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 4 people, 28.57%
High Blood Pressure: 4 people, 28.57%
Euphoric Mood (excessively happy but may become angry or irritable): 4 people, 28.57%
Insomnia (sleeplessness): 4 people, 28.57%
Psychomotor Hyperactivity (feelings of extreme restlessness): 4 people, 28.57%

What are the existing conditions these people have? *

Otitis (ear infection): 4 people, 28.57%
Bipolar Disorder (mood disorder): 4 people, 28.57%
Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 3 people, 21.43%
Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Midazolam and have Akathisia?

- Check whether Akathisia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Midazolam:

Midazolam (11,246 reports)

Akathisia treatments and more:

Akathisia (15,139 reports)

Browse all side effects of Midazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Akathisia:

Akathisia (440 drugs)

Browse all the conditions that are associated with Akathisia:

Akathisia (822 conditions)

Related publications that referenced our studies

Grover S, Sahoo S, "Clozapine induced akathisia: A case report and review of the evidence", Indian journal of pharmacology, 2015 Jan .
Grover S, Sahoo S, "Clozapine induced akathisia: A case report and review of the evidence", Indian journal of pharmacology, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on midazolam (the active ingredients of Midazolam) and Midazolam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.